RPHM - Dinamika pendapatan YoY sajrone rolas wulan kepungkur Reneo Pharmaceuticals, Inc

Logo grafis Reneo Pharmaceuticals, Inc (RPHM)

Reneo Pharmaceuticals (RPHM) minimizes commercial risks by developing small molecules for the therapy of rare mitochondrial pathologies in collaboration with scientific centers. The current stage of capital reallocation requires strict management oversight. High scaling potential is ensured by an intellectual monopoly on the drugs. This chart of trailing 12-month sales volume versus the previous year clearly demonstrates a trend where 0.00 expresses the metric's value today.

RPHM Reneo Pharmaceuticals Inc.: Wutah dodolan YoY sajrone rolas wulan kepungkur ing interval 11.02.2024 - 20.02.2024

reneopharma.com (RPHM) - rincian metrik lan laporan keuangan

- rega saham lan konsensus proyeksi valuasi:
Analisis kabeh metrik perusahaan:Reneo Pharma
Produk seri Reneo Pharmaceuticals

This metric reflects the percentage change in total commercial revenues over a rolling twelve-month period, allowing for an assessment of business scaling rates relative to the previous year. By analyzing the trailing twelve-month (TTM) sales growth, an investor can observe the transition of Reneo Pharmaceuticals (RPHM) from investment funding to the monetization of developments in the field of rare mitochondrial pathology therapies, which determines the company's future capitalization potential.

Karo sapa Reneo Pharmaceuticals saingan

VRTX (Vertex Pharmaceuticals Inc.) - Wutah dodolan taun lumaku|Alnylam Pharmaceuticals - Wutah dodolan YoY (TTM)|Dinamika pendapatan YoY sajrone rolas wulan kepungkur INSM (Insmed Incorporated)|UTHR: Wutah dodolan YoY (TTM)|BioMarin Pharmaceutical Inc. (BMRN) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY sajrone rolas wulan kepungkur BridgeBio Pharma Inc|Wutah pendapatan YoY sajrone 12 wulan kepungkur BGM Group Ltd (BGM)|Wutah dodolan YoY sajrone rolas wulan kepungkur cogentbio.com (COGT)|Wutah pendapatan YoY sajrone 12 wulan kepungkur Xeris Biopharma XERS|Wutah dodolan YoY (TTM) KROS (kerostx.com)|Wutah dodolan YoY (TTM) Arcturus Therapeutics Holdings Inc. ARCT|etonpharma.com - Wutah dodolan YoY (TTM)|KMDA - Wutah dodolan YoY (TTM)|FULC (Fulcrum Corp) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|ABEO (Abeona Therapeutics, Inc.) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur mereobiopharma.com|PLX (Protalix BioTherapeutics, Inc.) - Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan YoY (TTM) PLRX|Wutah dodolan YoY sajrone rolas wulan kepungkur APLT (Applied Therapeutics)|Rein Therapeutics Inc - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Gelteq Limited (GELS) - Wutah pendapatan taun lumaku|aytubio.com - Wutah dodolan YoY (TTM)|chemomab.com (CMMB) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|SRXH: Wutah dodolan YoY (TTM)|Wutah dodolan taun lumaku PLRZ (Polyrizon Ltd.)|Wutah pendapatan YoY sajrone 12 wulan kepungkur AEZS|CYTH: Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur inozyme.com (INZY)|CSCI (COSCIENS Biopharma) - Dinamika pendapatan YoY sajrone rolas wulan kepungkur